What are the major opportunities in the Insomnia market? What are the strategies for the Insomnia market?

For detailed insights on the major opportunities and strategies in the Insomnia market, Read More

How does the Insomnia market relate to the overall economy and other similar markets?

For detailed insights on Insomnia's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Insomnia market growth? SWOT analysis of the Insomnia market.

For detailed insights on the key dynamics influencing the Insomnia market growth and SWOT analysis of the Insomnia industry, Read More

Insomnia Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Insomnia Market Report 2026

Name: Insomnia Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Therapy Type (Non-Pharmacological Therapy, Pharmacological Therapy), By Drug Class (Anti-Depressants, Melatonin Antagonist, Benzodiazepines, Nonbenzodiazepines, Orexin Antagonist, Other Drug Classes), By Route Of Administration (Oral, Parenteral, Other Route Of Administration), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies ) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Insomnia Market Overview

• Insomnia market size has reached to $5.22 billion in 2025

• Expected to grow to $7.03 billion in 2030 at a compound annual growth rate (CAGR) of 6.3%

• Growth Driver: Rising Prevalence Of Chronic Diseases To Drive Market Growth

• Market Trend: Innovative Insomnia Drugs Reshaping The Market

• North America was the largest region in 2025.

What Is Covered Under Insomnia Market?

Insomnia is a sleep disorder in which the patient has trouble falling or staying asleep. Depending on the duration, the condition is either short-term (acute) or long-term (chronic). Drugs, digital therapeutics, and devices are used to treat insomnia conditions.

The main therapy types for insomnia are non-pharmacological therapy and pharmacological therapy. Non-pharmacological interventions (NPI) or non-pharmacological therapies refer to any non-chemical intervention performed on and benefiting the patient, such as light therapy and exercise. The various drug classes include anti-depressants, melatonin antagonist, benzodiazepines, nonbenzodiazepines, orexin antagonist, others. These are administered through various routes of administration such as oral, parenteral, and others, and are distributed through various distribution channels such as hospital pharmacies, retail pharmacies, and online pharmacies.

Insomnia Market Global Report 2026 Market Report bar graph

What Is The Insomnia Market Size and Share 2026?

The insomnia market size has grown strongly in recent years. It will grow from $5.22 billion in 2025 to $5.52 billion in 2026 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to rising prevalence of sleep disorders, increased stress and lifestyle changes, widespread use of benzodiazepines and sedatives, growing diagnosis rates of insomnia, expansion of sleep clinics and specialists.

What Is The Insomnia Market Growth Forecast?

The insomnia market size is expected to see strong growth in the next few years. It will grow to $7.03 billion in 2030 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to increasing adoption of digital therapeutics, growing demand for safer long-term insomnia treatments, rising geriatric population, increasing mental health awareness, expansion of online and retail pharmacy access. Major trends in the forecast period include growing adoption of non-pharmacological insomnia treatments, rising use of cognitive behavioral therapy for insomnia, increasing preference for personalized sleep management, expanding use of combination therapy approaches, growing awareness of chronic insomnia as a medical condition.

Book your 30 minutes free consultation with our research experts

Global Insomnia Market Segmentation

1) By Therapy Type: Non-Pharmacological Therapy, Pharmacological Therapy

2) By Drug Class: Anti-Depressants, Melatonin Antagonist, Benzodiazepines, Nonbenzodiazepines, Orexin Antagonist, Other Drug Classes

3) By Route Of Administration: Oral, Parenteral, Other Route Of Administration

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Non-Pharmacological Therapy: Cognitive Behavioral Therapy For Insomnia (CBT-I), Sleep Hygiene Education, Relaxation Techniques, Stimulus Control Therapy, Sleep Restriction Therapy

2) By Pharmacological Therapy: Prescription Medications, Over-The-Counter, Herbal Supplements

What Is The Driver Of The Insomnia Market?

The increasing prevalence of chronic diseases is expected to propel the growth of insomnia market going forward. Chronic disease refers to a form of illness that lasts for three months or more and can deteriorate with time. Individuals suffering from chronic diseases, such as cardiovascular disorders, diabetes, and chronic pain conditions, often experience insomnia or other sleep-related issues as a comorbidity. This increased prevalence creates a demand for effective insomnia treatments and management strategies, driving the market for products and services designed to address sleep disorders. For instance, in April 2025, according to the Centers for Disease Control and Prevention, a US-based federal public health agency, 76.4% of US adults representing about 194 million people reported having one or more chronic conditions in 2023, with prevalence at 59.5% among young adults, 78.4% among midlife adults, and 93.0% among older adults. Therefore, the increasing prevalence of chronic diseases is driving the growth of the insomnia industry.

Key Players In The Global Insomnia Market

Major companies operating in the insomnia market are Pfizer Inc., Merck & Co Inc., Sanofi S.A., GlaxoSmithKline plc., Takeda Pharmaceutical Company Limited, Koninklijke Philips N.V., Viatris Inc., Astellas Pharma Inc., Sun Pharmaceutical Industries Limited, Eisai Co.Ltd., UCLA Health Insomnia Clinic, Jazz Pharmaceuticals PLC, Aurobindo Pharma Limited, Purdue Pharma LP, Cipla Inc., Dr. Reddy's Laboratories Ltd., Zydus Lifesciences Limited, Lupin Limited, Mallinckrodt Pharmaceuticals Plc., Fisher & Paykel Healthcare Corporation Limited, ResMed Inc., Sunovion Pharmaceuticals Inc., Casper Sleep Inc., Biocodex Inc., Vanda Pharmaceuticals Inc., Pernix Therapeutics Holdings Inc., SleepScore Labs, Alpha-Stim, Neurim Pharmaceuticals Ltd., NightWare Inc.

Global Insomnia Market Trends and Insights

Major companies operating in the insomnia market are developing new products such as zaleplon-based insomnia drugs to gain a competitive edge in the market. Zaleplon is a non-benzodiazepine sedative-hypnotic medication used for the short-term treatment of insomnia. For instance, in April 2023, Bukwang Pharm Co Ltd., a South Korea-based pharmaceutical company, launched Zaledeep Cap., the first insomnia treatment in South Korea utilizing zaleplon as its main ingredient. Zaleplon, a non-benzodiazepine drug with FDA approval for treating insomnia, is known for its rapid onset of action, short half-life, and minimal impact on daily activities. With increasing insomnia cases in modern society, the launch of Zaledeep Cap. is expected to provide a new and effective treatment option, aiming to enhance sleep quality and overall well-being for individuals suffering from insomnia.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Insomnia Market?

In October 2023, dsm-firmenich N.V., a Netherlands-based health and nutrition science company, partnered with Bod Science Pty Ltd to advance the development of one of the world’s first cannabidiol (CBD)-based treatments for insomnia. With this partnership, dsm-firmenich N.V. and Bod Science Pty Ltd aim to progress Bod Science’s investigational cannabinoid therapy for insomnia, utilize dsm-firmenich N.V.’s good manufacturing practice (GMP)-certified pharmaceutical-grade CBD active ingredient to support clinical and regulatory advancement, improve consumer access through Australia’s emerging over-the-counter pathways, and accelerate the development of an innovative sleep-focused therapeutic option. Bod Science Pty Ltd is an Australia-based medical cannabis company that specializes in developing evidence-based CBD formulations for sleep and wellness applications.

Regional Outlook

North America was the largest region in the insomnia market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Insomnia Market?

The insomnia market consists of revenues earned by entities by providing therapies such as light therapy, stimulus control therapy, and relaxation therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The insomnia market also includes sales of triazolam, estazolam, temazepam, quazepam, and flurazepam. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Insomnia Market Report 2026?

The insomnia market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the insomnia industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Insomnia Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$5.52 billion
Revenue Forecast In 2035	$7.03 billion
Growth Rate	CAGR of 5.7% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Therapy Type, Drug Class, Route Of Administration, Distribution Channel
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Pfizer Inc., Merck & Co Inc., Sanofi S.A., GlaxoSmithKline plc., Takeda Pharmaceutical Company Limited, Koninklijke Philips N.V., Viatris Inc., Astellas Pharma Inc., Sun Pharmaceutical Industries Limited, Eisai Co.Ltd., UCLA Health Insomnia Clinic, Jazz Pharmaceuticals PLC, Aurobindo Pharma Limited, Purdue Pharma LP, Cipla Inc., Dr. Reddy's Laboratories Ltd., Zydus Lifesciences Limited, Lupin Limited, Mallinckrodt Pharmaceuticals Plc., Fisher & Paykel Healthcare Corporation Limited, ResMed Inc., Sunovion Pharmaceuticals Inc., Casper Sleep Inc., Biocodex Inc., Vanda Pharmaceuticals Inc., Pernix Therapeutics Holdings Inc., SleepScore Labs, Alpha-Stim, Neurim Pharmaceuticals Ltd., NightWare Inc.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Insomnia Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Insomnia Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Insomnia Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Insomnia Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Digitalization, Cloud, Big Data & Cybersecurity

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.4 Biotechnology, Genomics & Precision Medicine

4.1.5 Immersive Technologies (Ar/Vr/Xr) & Digital Experiences

4.2. Major Trends

4.2.1 Growing Adoption Of Non-Pharmacological Insomnia Treatments

4.2.2 Rising Use Of Cognitive Behavioral Therapy For Insomnia

4.2.3 Increasing Preference For Personalized Sleep Management

4.2.4 Expanding Use Of Combination Therapy Approaches

4.2.5 Growing Awareness Of Chronic Insomnia As A Medical Condition

5. Insomnia Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Sleep Clinics

5.3 Specialty Clinics

5.4 Home Healthcare Settings

5.5 Mental Health Centers

6. Insomnia Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Insomnia Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Insomnia PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Insomnia Market Size, Comparisons And Growth Rate Analysis

7.3. Global Insomnia Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Insomnia Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Insomnia Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Insomnia Market Segmentation

9.1. Global Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Non-Pharmacological Therapy, Pharmacological Therapy

9.2. Global Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Anti-Depressants, Melatonin Antagonist, Benzodiazepines, Nonbenzodiazepines, Orexin Antagonist, Other Drug Classes

9.3. Global Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Parenteral, Other Route Of Administration

9.4. Global Insomnia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

9.5. Global Insomnia Market, Sub-Segmentation Of Non-Pharmacological Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Cognitive Behavioral Therapy For Insomnia (CBT-I), Sleep Hygiene Education, Relaxation Techniques, Stimulus Control Therapy, Sleep Restriction Therapy

9.6. Global Insomnia Market, Sub-Segmentation Of Pharmacological Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Prescription Medications, Over-The-Counter, Herbal Supplements

10. Insomnia Market Regional And Country Analysis

10.1. Global Insomnia Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Insomnia Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Insomnia Market

11.1. Asia-Pacific Insomnia Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Insomnia Market, Segmentation By Therapy Type, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Insomnia Market

12.1. China Insomnia Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Insomnia Market, Segmentation By Therapy Type, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Insomnia Market

13.1. India Insomnia Market, Segmentation By Therapy Type, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Insomnia Market

14.1. Japan Insomnia Market Overview

14.2. Japan Insomnia Market, Segmentation By Therapy Type, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Insomnia Market

15.1. Australia Insomnia Market, Segmentation By Therapy Type, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Insomnia Market

16.1. Indonesia Insomnia Market, Segmentation By Therapy Type, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Insomnia Market

17.1. South Korea Insomnia Market Overview

17.2. South Korea Insomnia Market, Segmentation By Therapy Type, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Insomnia Market

18.1. Taiwan Insomnia Market Overview

18.2. Taiwan Insomnia Market, Segmentation By Therapy Type, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Insomnia Market

19.1. South East Asia Insomnia Market Overview

19.2. South East Asia Insomnia Market, Segmentation By Therapy Type, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Insomnia Market

20.1. Western Europe Insomnia Market Overview

20.2. Western Europe Insomnia Market, Segmentation By Therapy Type, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Insomnia Market

21.1. UK Insomnia Market, Segmentation By Therapy Type, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Insomnia Market

22.1. Germany Insomnia Market, Segmentation By Therapy Type, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Insomnia Market

23.1. France Insomnia Market, Segmentation By Therapy Type, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Insomnia Market

24.1. Italy Insomnia Market, Segmentation By Therapy Type, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Insomnia Market

25.1. Spain Insomnia Market, Segmentation By Therapy Type, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Insomnia Market

26.1. Eastern Europe Insomnia Market Overview

26.2. Eastern Europe Insomnia Market, Segmentation By Therapy Type, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Insomnia Market

27.1. Russia Insomnia Market, Segmentation By Therapy Type, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Insomnia Market

28.1. North America Insomnia Market Overview

28.2. North America Insomnia Market, Segmentation By Therapy Type, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Insomnia Market

29.1. USA Insomnia Market Overview

29.2. USA Insomnia Market, Segmentation By Therapy Type, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Insomnia Market

30.1. Canada Insomnia Market Overview

30.2. Canada Insomnia Market, Segmentation By Therapy Type, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Insomnia Market

31.1. South America Insomnia Market Overview

31.2. South America Insomnia Market, Segmentation By Therapy Type, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Insomnia Market

32.1. Brazil Insomnia Market, Segmentation By Therapy Type, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Insomnia Market

33.1. Middle East Insomnia Market Overview

33.2. Middle East Insomnia Market, Segmentation By Therapy Type, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Insomnia Market

34.1. Africa Insomnia Market Overview

34.2. Africa Insomnia Market, Segmentation By Therapy Type, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Insomnia Market Regulatory and Investment Landscape

36. Insomnia Market Competitive Landscape And Company Profiles

36.1. Insomnia Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Insomnia Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Insomnia Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. GlaxoSmithKline plc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis

37. Insomnia Market Other Major And Innovative Companies

Koninklijke Philips N.V., Viatris Inc., Astellas Pharma Inc., Sun Pharmaceutical Industries Limited, Eisai Co.Ltd., UCLA Health Insomnia Clinic, Jazz Pharmaceuticals PLC, Aurobindo Pharma Limited, Purdue Pharma LP, Cipla Inc., Dr. Reddy's Laboratories Ltd., Zydus Lifesciences Limited, Lupin Limited, Mallinckrodt Pharmaceuticals Plc., Fisher & Paykel Healthcare Corporation Limited

38. Global Insomnia Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Insomnia Market

40. Insomnia Market High Potential Countries, Segments and Strategies

40.1 Insomnia Market In 2030 - Countries Offering Most New Opportunities

40.2 Insomnia Market In 2030 - Segments Offering Most New Opportunities

40.3 Insomnia Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Insomnia Market, Overview Of Key Products - Product Examples

Table 2: Global Insomnia Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Insomnia Market, Supply Chain Analysis

Table 4: Global Insomnia Market, Major Raw Material Providers

Table 5: Global Insomnia Market, Major Resource Providers

Table 6: Global Insomnia Market, Major Manufacturers (Suppliers)

Table 7: Global Insomnia Market, Major Distributors And Channel Partners

Table 8: Global Insomnia Market, Key Technologies & Future Trends

Table 9: Global Insomnia Market, Major Trends

Table 10: Global Insomnia Market, Major End Users

Table 11: Global Insomnia Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Insomnia Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Insomnia Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Insomnia Market - TAM, US$ Billion, 2025

Table 15: Global Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Insomnia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Insomnia Market, Sub-Segmentation Of Non-Pharmacological Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Insomnia Market, Sub-Segmentation Of Pharmacological Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Insomnia Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Insomnia Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Asia-Pacific, Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: China, Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: India, Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Japan, Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Australia, Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Indonesia, Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: South Korea, Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Taiwan, Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South East Asia, Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Western Europe, Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: UK, Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Germany, Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: France, Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Italy, Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Spain, Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Eastern Europe, Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Russia, Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: North America, Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: USA, Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: Canada, Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: South America, Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Brazil, Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Middle East, Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Africa, Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Global Insomnia Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 96: Global Insomnia Market - Company Scoring Matrix

Table 97: Pfizer Inc. Financial Performance

Table 98: Merck & Co Inc. Financial Performance

Table 99: Sanofi S.A. Financial Performance

Table 100: GlaxoSmithKline plc. Financial Performance

Table 101: Takeda Pharmaceutical Company Limited Financial Performance

Table 102: Global Insomnia Market, Competitive Benchmarking (In USD Billions)

Table 103: Global Insomnia Market, Competitive Dashboard

Table 104: Global Insomnia Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 105: Global, Insomnia Market Size Gain ($ Billion), Segmentation By Therapy Type, 2025 – 2030

Table 106: Global, Insomnia Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030

Table 107: Global, Insomnia Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

List Of Figures

Figure 1: Global Insomnia Market, Overview Of Key Products - Product Examples

Figure 2: Global Insomnia Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Insomnia Market, Supply Chain Analysis

Figure 4: Global Insomnia Market, Major Raw Material Providers

Figure 5: Global Insomnia Market, Major Resource Providers

Figure 6: Global Insomnia Market, Major Manufacturers (Suppliers)

Figure 7: Global Insomnia Market, Major Distributors And Channel Partners

Figure 8: Global Insomnia Market, Key Technologies & Future Trends

Figure 9: Global Insomnia Market, Major Trends

Figure 10: Global Insomnia Market, Major End Users

Figure 11: Global Insomnia Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Insomnia Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Insomnia Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Insomnia Market - TAM, US$ Billion, 2025

Figure 15: Global Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Insomnia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Insomnia Market, Sub-Segmentation Of Non-Pharmacological Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Insomnia Market, Sub-Segmentation Of Pharmacological Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Insomnia Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Insomnia Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Asia-Pacific, Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: China, Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: India, Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Japan, Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Australia, Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Indonesia, Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: South Korea, Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Taiwan, Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South East Asia, Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Western Europe, Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: UK, Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Germany, Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: France, Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Italy, Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Spain, Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Eastern Europe, Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Russia, Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: North America, Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: USA, Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: Canada, Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: South America, Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Brazil, Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Middle East, Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Africa, Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Global Insomnia Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 96: Global Insomnia Market - Company Scoring Matrix

Figure 97: Pfizer Inc. Financial Performance

Figure 98: Merck & Co Inc. Financial Performance

Figure 99: Sanofi S.A. Financial Performance

Figure 100: GlaxoSmithKline plc. Financial Performance

Figure 101: Takeda Pharmaceutical Company Limited Financial Performance

Figure 102: Global Insomnia Market, Competitive Benchmarking (In USD Billions)

Figure 103: Global Insomnia Market, Competitive Dashboard

Figure 104: Global Insomnia Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 105: Global, Insomnia Market Size Gain ($ Billion), Segmentation By Therapy Type, 2025 – 2030

Figure 106: Global, Insomnia Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030

Figure 107: Global, Insomnia Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

Global Insights: Predictive Genetic Testing And Consumer Genomics Market Expected to Surpass $16.14 Billion by 2029

Future Projections: Prescription Delivery Service Market to Reach $32.61 Billion by 2029 at 13% CAGR

Latest Market Developments in Radio Frequency Identification (RFID) In Pharmaceuticals Industry: Forecast 2025–2029

Strategic Report on Salt Therapy Market: Growth Opportunities and Emerging Challenges

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Sleeping Aids Market Report 2026 - Global Outlook – By Product (Mattresses And Pillows, Sleep Laboratories, Medications, Prescription-Based Drugs, OTC Drugs, Herbal Drugs, Sleep Apnea Devices), By Indication (Insomnia, S...

Dental Sleep Medicine Market Report 2026 - Global Outlook – By Type (Diagnostic, Treatment), By Age Group (Pediatric, Adult, Geriatric), By End User (Hospitals, Sleep Laboratories, Home, Other End Users) - Market Size, T...

Sleep Monitoring Apps Market Report 2026 - Global Outlook – By Operating System (iPhone Operating System (iOS), Android), By Subscription Model (Paid, Monthly, Annually, Free), By Application (Sleep Quality Tracking, Hea...

Sleep Testing Services Market Report 2026 - Global Outlook – By Diagnostic Type (Home Sleep Testing, In-Lab Sleep Testing), By Application (Obstructive Sleep Apnea, Insomnia, Rapid Eye Movement (REM) Sleep Disorder, Rest...

Sleep Tech Devices Market Report 2026 - Global Outlook – By Product Type ( Wearable, Monitoring Devices, Smart Gadgets, Digital Tools, Other Types), By Age ( Below 45 Years, 45–64 Years, Above 65 Years), By Distribution ...

Sleep Study Equipment Market Report 2026 - Global Outlook – By Type (Sleep Monitors, Masks And Interfaces, Sensors And Accessories, Smart Beds And Pillows, Other Types), By Distribution Channel (Online Sales, Offline Sal...

Panic Disorders Market Report 2026 - Global Outlook – By Treatment Type (Pharmacotherapies, Psychotherapeutic Interventions, Digital Or Tech-Enabled Therapies), By Disorder Type (Panic Disorder Without Agoraphobia, Panic...

Frequently Asked Questions

How big is the Insomnia Market?

The Insomnia market was valued at $5.22 billion in 2025, increased to $5.52 billion in 2026, and is projected to reach $7.03 billion by 2030. request a sample here

What is the Insomnia market growth?

The global Insomnia market is expected to grow at a CAGR of 6.3% from 2026 to 2035 to reach $7.03 billion by 2035. request a sample here

Who are the key players in Insomnia market?

Some Key Players in the Insomnia market Include, Pfizer Inc., Merck & Co Inc., Sanofi S.A., GlaxoSmithKline plc., Takeda Pharmaceutical Company Limited, Koninklijke Philips N.V., Viatris Inc., Astellas Pharma Inc., Sun Pharmaceutical Industries Limited, Eisai Co.Ltd., UCLA Health Insomnia Clinic, Jazz Pharmaceuticals PLC, Aurobindo Pharma Limited, Purdue Pharma LP, Cipla Inc., Dr. Reddy's Laboratories Ltd., Zydus Lifesciences Limited, Lupin Limited, Mallinckrodt Pharmaceuticals Plc., Fisher & Paykel Healthcare Corporation Limited, ResMed Inc., Sunovion Pharmaceuticals Inc., Casper Sleep Inc., Biocodex Inc., Vanda Pharmaceuticals Inc., Pernix Therapeutics Holdings Inc., SleepScore Labs, Alpha-Stim, Neurim Pharmaceuticals Ltd., NightWare Inc. . request a sample here

What is the anticipated growth trend for the Insomnia market?

Major trend in this market includes: Innovative Insomnia Drugs Reshaping The Market. For further insights on this market. request a sample here

Which region has the most growth potential in the Insomnia market?

North America was the largest region in the insomnia market in 2025. The regions covered in the insomnia market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Who are the key players in the Insomnia Market Report 2026 market?

Major companies operating in the Insomnia Market Report 2026 market are Major companies operating in the insomnia market are Pfizer Inc., Merck & Co Inc., Sanofi S.A., GlaxoSmithKline plc., Takeda Pharmaceutical Company Limited, Koninklijke Philips N.V., Viatris Inc., Astellas Pharma Inc., Sun Pharmaceutical Industries Limited, Eisai Co.Ltd., UCLA Health Insomnia Clinic, Jazz Pharmaceuticals PLC, Aurobindo Pharma Limited, Purdue Pharma LP, Cipla Inc., Dr. Reddy's Laboratories Ltd., Zydus Lifesciences Limited, Lupin Limited, Mallinckrodt Pharmaceuticals Plc., Fisher & Paykel Healthcare Corporation Limited, ResMed Inc., Sunovion Pharmaceuticals Inc., Casper Sleep Inc., Biocodex Inc., Vanda Pharmaceuticals Inc., Pernix Therapeutics Holdings Inc., SleepScore Labs, Alpha-Stim, Neurim Pharmaceuticals Ltd., NightWare Inc. request a sample here.

Which region has the most growth potential in the Insomnia Market Report 2026 market?